Assessing genetic‐based therapies for AIDS using the simian immunodeficiency virus

Carla L. Endres, Eric Bergquam, Michael K. Axthelm, Scott W. Wong

Research output: Contribution to journalArticlepeer-review

3 Scopus citations


Abstract: A plasmid encoding the full‐length infectious molecular proviral clone of SIVmac239 was generated. Virus derived from cells transfected with this clone replicated to high levels and was cytopathic for some transformed human CD4+ cell lines and primary rhesus macaque peripheral blood mononuclear cells. Since replication of SIV requires the functional expression of the viral encoded rev protein, transient co‐transfection studies were initiated with the infectious proviral clone and a well‐characterized trans‐dominant negative HIV‐1 rev mutant. 1995 Munksgaard

Original languageEnglish (US)
Pages (from-to)141-144
Number of pages4
JournalJournal of medical primatology
Issue number3
StatePublished - May 1995


  • HIV
  • SIV
  • antiviral
  • gene therapy
  • retrovirus
  • transient transfection

ASJC Scopus subject areas

  • Animal Science and Zoology
  • veterinary(all)


Dive into the research topics of 'Assessing genetic‐based therapies for AIDS using the simian immunodeficiency virus'. Together they form a unique fingerprint.

Cite this